Lynx1 Capital Management LP - Jun 30, 2025 SCHEDULE 13G/A Report for TScan Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (TCRX)

Filing Manager: Lynx1 Capital Management LP
Reporting Manager: Lynx1 Capital Management LP
Security: TScan Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share
Symbol: TCRX
Shares outstanding: 52.4M shares
Disclosed Ownership: 7.86M shares
Ownership: 15%
Form type: SCHEDULE 13G/A
Date filed: 8/14/2025, 07:06 AM
Date of event: Jun 30, 2025
Previous filing: Feb 14, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Lynx1 Capital Management LP	15%	7.86M	0	7.86M	/s/ Weston Nichols	By: Lynx1 Capital Management GP LLC, General Partner, By: Weston Nichols, Sole Member
Weston Nichols	15%	7.86M	0	7.86M	/s/ Weston Nichols	Weston Nichols, Individually